Neurogene Inc (NGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -75,144 | -55,630 | -35,413 | -16,921 | -36,317 |
| Depreciation Amortization | 828 | 989 | 870 | 379 | 3,192 |
| Accounts payable and accrued liabilities | -77 | 339 | 368 | 135 | 667 |
| Other Working Capital | -5,961 | -5,065 | -7,628 | -6,749 | -4,023 |
| Other Operating Activity | 9,751 | 6,260 | 4,260 | 1,506 | -14,941 |
| Operating Cash Flow | $-70,603 | $-53,107 | $-37,543 | $-21,650 | $-51,422 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -808 | -692 | -525 | -65 | -321 |
| Purchase Of Investment | -198,453 | -80,203 | -42,654 | N/A | N/A |
| Sale Of Investment | 74,000 | 58,250 | 49,500 | 30,000 | 5,000 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 20,958 |
| Investing Cash Flow | $-125,261 | $-22,645 | $6,321 | $29,935 | $25,637 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 92,343 |
| Debt Repayment | -52 | -39 | -27 | -11 | -29 |
| Common Stock Issued | 191,265 | 1,187 | 1,044 | 629 | 168 |
| Other Financing Activity | -7,142 | -7,142 | -7,142 | -7,142 | 0 |
| Financing Cash Flow | $184,071 | $-5,994 | $-6,125 | $-6,524 | $92,482 |
| Beginning Cash Position | 148,718 | 148,718 | 148,718 | 148,718 | 82,021 |
| End Cash Position | 136,925 | 66,972 | 111,371 | 150,479 | 148,718 |
| Net Cash Flow | $-11,793 | $-81,746 | $-37,347 | $1,761 | $66,697 |
| Free Cash Flow | |||||
| Operating Cash Flow | -70,603 | -53,107 | -37,543 | -21,650 | -51,422 |
| Capital Expenditure | -808 | -692 | -525 | -65 | -321 |
| Free Cash Flow | -71,411 | -53,799 | -38,068 | -21,715 | -51,743 |